Mara Serbanescu, Seoho Lee, Fengying Li, Sri Harsha Boppana, Mohamed Elebasy, James R White, C David Mintz
{"title":"Effects of Perioperative Exposure on the Microbiome and Outcomes From an Immune Challenge in C57Bl/6 Adult Mice.","authors":"Mara Serbanescu, Seoho Lee, Fengying Li, Sri Harsha Boppana, Mohamed Elebasy, James R White, C David Mintz","doi":"10.1213/ANE.0000000000007467","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous work suggests that the gut microbiome can be disrupted by antibiotics, anesthetics, opiates, supplemental oxygen, or nutritional deprivation-all of which are common and potentially modifiable perioperative interventions that nearly all patients are exposed to in the setting of surgery. Gut microbial dysbiosis has been postulated to be a risk factor for poor surgical outcomes, but how perioperative care-independent of the surgical intervention-impacts the gut microbiome, and the potential consequences of this impact have not been directly investigated.</p><p><strong>Methods: </strong>We developed a perioperative exposure model (PEM) in C57Bl/6 mice to emulate the most common elements of perioperative medicine other than surgery, which included 12 hours of nutritional deprivation, 4 hours of volatile general anesthetic, 7 hours of supplemental oxygen, surgical antibiotics (cefazolin), and opioid pain medication (buprenorphine). Gut microbial dynamics and inferred metabolic changes were longitudinally assessed before-and at 3 time points after-PEM by 16S rRNA amplicon sequencing. We then used fecal microbial transplant in secondary abiotic mice to test if, compared to preexposure microbiota, day 3 post-PEM microbial communities affect the clinical response to immune challenge in an endotoxemia model.</p><p><strong>Results: </strong>We observed transient changes in microbiota structure and function after the PEM, including reduced biodiversity, loss of diverse commensals associated with health (including Lactobacillus , Roseburia , and Ruminococcus ), and changes in microbiota-mediated amino acid metabolic pathways. Mice engrafted with day 3 post-PEM microbial communities demonstrated markedly reduced survival after endotoxemia compared to those bearing preexposure communities (7-day survival of ~20% vs ~70%, P = .0002).</p><p><strong>Conclusions: </strong>These findings provide the first clear evidence that the combined effects of common perioperative factors, independent of surgery, cause gut microbial dysbiosis and alter the host response to inflammation in the postoperative period.</p>","PeriodicalId":7784,"journal":{"name":"Anesthesia and analgesia","volume":" ","pages":"171-180"},"PeriodicalIF":3.8000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12353306/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesia and analgesia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1213/ANE.0000000000007467","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Previous work suggests that the gut microbiome can be disrupted by antibiotics, anesthetics, opiates, supplemental oxygen, or nutritional deprivation-all of which are common and potentially modifiable perioperative interventions that nearly all patients are exposed to in the setting of surgery. Gut microbial dysbiosis has been postulated to be a risk factor for poor surgical outcomes, but how perioperative care-independent of the surgical intervention-impacts the gut microbiome, and the potential consequences of this impact have not been directly investigated.
Methods: We developed a perioperative exposure model (PEM) in C57Bl/6 mice to emulate the most common elements of perioperative medicine other than surgery, which included 12 hours of nutritional deprivation, 4 hours of volatile general anesthetic, 7 hours of supplemental oxygen, surgical antibiotics (cefazolin), and opioid pain medication (buprenorphine). Gut microbial dynamics and inferred metabolic changes were longitudinally assessed before-and at 3 time points after-PEM by 16S rRNA amplicon sequencing. We then used fecal microbial transplant in secondary abiotic mice to test if, compared to preexposure microbiota, day 3 post-PEM microbial communities affect the clinical response to immune challenge in an endotoxemia model.
Results: We observed transient changes in microbiota structure and function after the PEM, including reduced biodiversity, loss of diverse commensals associated with health (including Lactobacillus , Roseburia , and Ruminococcus ), and changes in microbiota-mediated amino acid metabolic pathways. Mice engrafted with day 3 post-PEM microbial communities demonstrated markedly reduced survival after endotoxemia compared to those bearing preexposure communities (7-day survival of ~20% vs ~70%, P = .0002).
Conclusions: These findings provide the first clear evidence that the combined effects of common perioperative factors, independent of surgery, cause gut microbial dysbiosis and alter the host response to inflammation in the postoperative period.
背景:先前的研究表明,肠道微生物群可能被抗生素、麻醉剂、阿片类药物、补充氧气或营养剥夺所破坏——所有这些都是常见的、可能改变的围手术期干预措施,几乎所有患者在手术环境中都暴露于这些干预措施。肠道微生物失调被认为是手术预后不良的一个危险因素,但围手术期护理(独立于手术干预)如何影响肠道微生物群,以及这种影响的潜在后果尚未直接研究。方法:我们建立了C57Bl/6小鼠围手术期暴露模型(PEM),模拟除手术外最常见的围手术期药物,包括12小时营养剥夺,4小时挥发性全麻,7小时补充氧气,手术抗生素(头孢唑林)和阿片类止痛药(丁丙诺啡)。通过16S rRNA扩增子测序,在pem前后的3个时间点纵向评估肠道微生物动力学和推断的代谢变化。然后,我们在继发性非生物小鼠中使用粪便微生物移植来测试,与暴露前的微生物群相比,pem后第3天的微生物群落是否会影响内毒素血症模型中对免疫挑战的临床反应。结果:我们观察到PEM后微生物群结构和功能的短暂变化,包括生物多样性降低,与健康相关的多种共生菌(包括乳杆菌、玫瑰菌和Ruminococcus)的丧失,以及微生物群介导的氨基酸代谢途径的变化。与暴露前的微生物群落相比,移植了第3天pem后微生物群落的小鼠在内毒素血症后的存活率明显降低(7天存活率为20% vs 70%, P = 0.0002)。结论:这些发现首次提供了明确的证据,表明围手术期常见因素的综合作用,独立于手术,导致肠道微生物生态失调,并改变了术后宿主对炎症的反应。
期刊介绍:
Anesthesia & Analgesia exists for the benefit of patients under the care of health care professionals engaged in the disciplines broadly related to anesthesiology, perioperative medicine, critical care medicine, and pain medicine. The Journal furthers the care of these patients by reporting the fundamental advances in the science of these clinical disciplines and by documenting the clinical, laboratory, and administrative advances that guide therapy. Anesthesia & Analgesia seeks a balance between definitive clinical and management investigations and outstanding basic scientific reports. The Journal welcomes original manuscripts containing rigorous design and analysis, even if unusual in their approach.